Monteverde & Associates Launches Investigations into Four Corporate Mergers
Law firm Monteverde & Associates is reviewing the terms of four pending corporate acquisitions to determine if they adequately protect shareholder interests.
New York-based law firm Monteverde & Associates has initiated investigations into the mergers and acquisitions of Range Resources Corporation, Surgery Partners, Bolt Biotherapeutics, and Pacira BioSciences. The firm is analyzing whether the proposed deal terms are fair to minority shareholders.
For Range Resources, the investigation focuses on its planned merger with EQT Corporation, which involves a stock-for-stock exchange ratio of 0.987. Regarding Surgery Partners and Pacira BioSciences, the firm is reviewing the respective cash-per-share offers of $23.50 and $36.50. Additionally, the merger between Bolt Biotherapeutics and Prana Therapies is under scrutiny to ensure all governance standards were maintained throughout the negotiation process.
Such investigations are common in the wake of major corporate announcements, where legal firms assess whether directors adhered to their fiduciary duties. Monteverde & Associates is inviting shareholders of these companies to seek legal consultation regarding their rights and the potential fairness of the transaction terms.